Take part in the National Week for Cardiometabolic Diseases
Discover the 2026 program
3 weeks of awareness-raising, with a highlight from April 6 to 12, 2026
- Assess your cardiometabolic risk score in just a few clicks
- Attend the online talks / webinars led by scientific and medical experts
- Join the awareness day at the Pitié-Salpêtrière site
- Take part in the workshops Obesity Disease Workshop online or in person
- Listen to the podcast “At the Heart of Health”
- Join the connected physical activity challenge ICAN GO (reserved for challenge partners)
- Collaborate during the scientific day (reserved for our scientific community)
Cardiometabolic diseases: we are all concerned!
Diabetes, obesity, dyslipidemias, fatty liver disease (MASH), high blood pressure, are chronic metabolic conditions. When associated with cardiovascular diseases, they are called cardiometabolic diseases (CMD), and they concern us all !*
In France:
- A real public health issue affecting millions of people,
- The leading modifiable and preventable cause of cardiovascular diseases, which are the leading cause of death in women and the second leading cause of death in the general population, with more than 140,000 deaths per year linked to cardiovascular diseases and strokes according to Santé publique France.
In response to these alarming findings and the general public’s lack of awareness about these diseases (highlighted by the IHU ICAN barometer*), ICAN is launching in 2026 its 3rd national awareness week after the first edition held in April 2024.
This awareness week aims to shine a light on cardiometabolic diseases, as these chronic conditions disrupt many people’s quality of life and can lead to very serious, even life-threatening conditions. It is urgent to act to prevent them better, and also to provide researchers with the resources to make progress in this field.
“ Our goal is to spark awareness that leads to lasting behavior change, and to earlier screening for cardiometabolic diseases, enabling anticipatory and personalized care for those affected. We also need to provide more resources for research to accelerate innovation in cardiometabolism. ”
Prof. Stéphane Hatem, CEO of IHU ICAN
OUR partners
Take part in our initiatives
1. Learn more and assess your cardiometabolic risk score
From March 30 to April 19, find our awareness messages to learn more about this public health issue: social media, streaming platforms, web radios and radio stations (local, regional and national), posters…
IHU ICAN also offers a cardiometabolic risk assessment tool, free and 100% online, combining two medically recognized tools: the FINDRISC score and Score2.
This prediction tool is solely intended to provide, based on the data entered, general information about cardiometabolic risk over the next 10 years, to better understand one’s health status and any measures that may be needed to preserve it.
2. Register for our online talks (webinars)
Nutrition: a major lever for cardiometabolic prevention
March 30, 2026: 3:30 p.m. – 4:30 p.m.
Speakers:
→ Dr Raluca Pais: gastro-hepatologist, Hepatology Department, Pitié-Salpêtrière Hospital – AP-HP, IHU ICAN
→ Dr Silvia Barretta: investigator physician, IHU ICAN
→ Poids Plumes France Association
→ La Ligue contre l’Obésité Association
Innovation in the management of cardiometabolic diseases
April 10, 2026: 1:00 p.m. – 2:00 p.m.
Speakers:
→ Dr Catherine Grenier, National Medical Advisor – CNAM
→ Prof. Bruno Fève, Endocrinologist, Head of the Lipodystrophies, metabolic and hormonal adaptations, and aging team at the Saint-Antoine Research Center
→ Poids Plumes France Association
→ Daniel Jaouen, patient partner
Metabolic steatosis and liver cancer
April 14, 2026: 4:00 p.m. – 5:00 p.m.
→ Dr Raluca Pais, gastro-hepatologist,
Hepatology Department, Pitié-Salpêtrière Hospital – AP-HP, IHU ICAN.
→ Dr Manon Allaire, gastro-hepatologist, Hepatology Department, Pitié-Salpêtrière Hospital – AP-HP.
→ Selly Seckout, Director of the SOS Hépatites & liver disease association
→ Dominique Ravier, Expert patient, Amicale des Transplantés de la Pitié Salpêtrière
2025: Obesity: diseases, management and metabolic risks
2025: MASH, essential multidisciplinary care
2025: Homozygous and heterozygous familial hypercholesterolemia
2025: Type 2 diabetes and cardiovascular complications
2025: Physical activity: a new pillar in the management of heart disease
3. Join our awareness day on April 13
IHU ICAN is organizing on April 13, 2026 from 10 a.m. to 4 p.m. a unique day dedicated to raising awareness about cardiometabolic diseases at the Pitié-Salpêtrière Hospital site.
• Program : type 2 diabetes prevention (FINDRISC test and blood glucose measurement), prevention of metabolic hepatic steatosis, blood pressure measurement…
• Location : E3M building lobby, Pitié-Salpêtrière Hospital
Free. No registration required.
4. Take part in our “Obesity Workshop” sessions on April 7, 16 and 17
The Obesity Disease Workshop is a session that invites us to better understand the disease, its multiple causes and consequences, and to find individual and collective courses of action that contribute to better care for those affected.
Registration is free but mandatory (maximum 10 participants per session).
- April 7, 2026 | 2 sessions: 2:00 p.m.-3:30 p.m. or 4:30 p.m.-6:00 p.m. | In person at the Pitié-Salpêtrière site (Claude Bernard building)
- April 16, 2026 | 2 sessions: 10:00 a.m.-11:30 a.m. or 12:30 p.m.-2:00 p.m. | In person at the Sorbonne University Faculty of Medicine
- April 17, 2026 : 1 session: 12:00 p.m.-1:30 p.m. | Online (videoconference)
5. Listen to our podcast “At the Heart of Health”
Listen now to our podcast “ At the Heart of Health: the cardiometabolic disease news flash ”, available on SoundCloud, Spotify, Deezer and YouTube.
In this series, 10 informational segments illustrated by interviews with doctors and researchers on cardiometabolic diseases and advances in research.
Enjoy listening!
Reserved for IHU ICAN partners or the scientific community
6. Join our connected physical activity challenge, ICAN GO
From March 30 to April 19, IHU ICAN is running the 2nd edition of ICAN GO, a connected physical activity challenge to raise awareness of the benefits of physical activity in the management of cardiometabolic diseases
Reserved for the IHU ICAN community, partner sponsors and patient associations.
Registration via the link received by email. Contact: communication@ihuican.org.
7. Collaborate during our scientific day on April 9
A day paced by plenary sessions led by eminent figures in research.
Reserved for members of the scientific community.
Registration via the link received by email. Contact: communication@ihuican.org.
To go further
Cardiometabolism
Diabetes, obesity, fatty liver disease (MASH) or familial hypercholesterolemia are chronic conditions. When associated with heart diseases, they are called cardiometabolic diseases.
Cardiometabolic diseases are lifelong diseases. They are chronic conditions that patients must learn to manage to avoid acute episodes that lead to hospitalizations and worsening of the disease.
It is therefore absolutely essential to have comprehensive care for cardiometabolic diseases.
Diabetes
Since 1980, the number of cases has quadrupled worldwide. 1 in 20 people globally has diabetes. It is the 9th leading cause of death worldwide (1.5 million deaths per year), and the number of deaths due to diabetes has increased by 70% since 2000. In France, nearly 4 million people take treatment for diabetes. It is a disease that causes many complications : blindness, kidney failure, lower limb amputations, heart failure…
Obesity
Resulting from an imbalance between energy intake and expenditure, obesity corresponds to an excess of body fat with harmful health consequences. Worldwide, the number of people with obesity has tripled since 1975: 13% of adults have obesity and 39% are overweight. In France, obesity affects 17% of adults. This condition also increasingly affects children and adolescents. Among those under 18, it affects 16% of boys and 18% of girls.
Familial hypercholesterolemia
One of the most common genetic diseases in the world and in France, it can cause neuro-cardiovascular complications (strokes, acute coronary syndromes…) in young adults, and even children. Unfortunately, it is too often underdiagnosed, yet it is a real public health issue : an estimated 225,000 to 270,000 people are affected in France, with only 10% of adults and 5% of children diagnosed.
Fatty liver disease (MASH)
Also known as “fatty liver disease,” metabolic steatohepatitis or “MASH” is a chronic disease due to the accumulation of fat in the liver (steatosis), associated with metabolic risk factors (obesity, type 2 diabetes…), but not linked to excessive alcohol consumption. MASH (formerly called NASH) is a disease in constant evolution worldwide. The number of individuals with metabolic steatosis is rising sharply and will continue to increase in the coming years, notably due to the resurgence of type 2 diabetes and obesity around the world : 18% of the adult population in France is affected (25% worldwide, 32% in the United States).
Heart and blood vessel diseases
Cardiovascular diseases are one of the leading causes of death in Europe and the leading cause of death worldwide before age 65. They are responsible for cardiac arrhythmias, high blood pressure, myocardial infarction, heart failure and strokes. The most common condition is atherosclerosis, a phenomenon of accelerated aging and stiffening of the arteries, which can be blocked by atheroma plaques, thereby becoming the leading cause of myocardial infarction. This disease is promoted by metabolic diseases, a diet rich in animal fat, physical inactivity, smoking and heredity.
Support research alongside us
Alongside lifestyle-related risk factors, other factors must also be considered, such as genetic predispositions. In this case, only medical and scientific research can provide answers. It is therefore essential to give researchers the resources to carry out innovative research programs.
This is the mission of 230 researchers and 170 physicians at IHU ICAN. Thanks to their commitment, it will be possible to change the lives of millions of people.
Support from sponsors and donors is essential to accelerate this fight. Let’s give researchers the means to speed up innovation in cardiometabolic diseases. Make a donation to IHU ICAN to support the excellence of French research against cardiometabolic diseases.
Votre soutien est essentiel pour accélérer la recherche !
Pour en savoir plus, votre contact privilégié :
Francine Trocmé
Direction communication et mécénat
06 81 64 97 88 – f.trocme@ihuican.org
